FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Govan

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Procedures

Anatomy

Sputum

Concepts & Ideas

Molecular Sequence Data

Phenomena

Co-author Network

Publications

TOP 3
James D Chalmers; Catherine Docherty; John R W Govan; Brian J McHugh; Adam T Hill
Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis.
F J Gilchrist; John R W Govan; R Bright-Thomas; Catherine J Doherty; M France; A Kevin Webb; Andrew M Jones
Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?
Peter G Barlow; Paula E Beaumont; Celine Cosseau; Annie Mackellar; Thomas S Wilkinson; Robert E W Hancock; Chris Haslett; John R W Govan; A John Simpson; Donald J Davidson
The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Govan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James D Chalmers; Catherine Docherty; John R W Govan; Brian J McHugh; Adam T Hill
Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis.
Thorax 2013;68(1):39-47.
2011: F J Gilchrist; John R W Govan; R Bright-Thomas; Catherine J Doherty; M France; A Kevin Webb; Andrew M Jones
Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2011;38(6):1483-6.
2010: Peter G Barlow; Paula E Beaumont; Celine Cosseau; Annie Mackellar; Thomas S Wilkinson; Robert E W Hancock; Chris Haslett; John R W Govan; A John Simpson; Donald J Davidson
The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium.
American journal of respiratory cell and molecular biology 2010;43(6):692-702.
2010: D Macdonald; L Cuthbertson; C Doherty; S Campana; N Ravenni; G Taccetti; John R W Govan
Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
The Journal of antimicrobial chemotherapy 2010;65(11):2373-5.
2010: Natalie L Reynolds; Martin De Cecco; Karen Taylor; Chloe Stanton; Fiona M Kilanowski; Jason Kalapothakis; Emily Seo; Dusan Uhrin; Dominic J Campopiano; John R W Govan; Derek Macmillan; Perdita E Barran; Julia R Dorin
Peptide fragments of a beta-defensin derivative with potent bactericidal activity.
Antimicrobial agents and chemotherapy 2010;54(5):1922-9.
2010: David J Clarke; Ximena P Ortega; C Logan Mackay; Miguel A Valvano; John R W Govan; Dominic J Campopiano; Pat Langridge-Smith; Alan Brown
Subdivision of the bacterioferritin comigratory protein family of bacterial peroxiredoxins based on catalytic activity.
Biochemistry 2010;49(6):1319-30.
2009: Slade Loutet; S Josefin Bartholdson; John R W Govan; Dominic J Campopiano; Miguel A Valvano
Contributions of two UDP-glucose dehydrogenases to viability and polymyxin B resistance of Burkholderia cenocepacia.
Microbiology (Reading, England) 2009;155(Pt 6):2029-39.
2009: Thomas S Wilkinson; Kevin Dhaliwal; Thomas W Hamilton; Alexander F Lipka; Lesley Farrell; Donald J Davidson; Rodger Duffin; Andrew Conway Morris; Christopher Haslett; John R W Govan; Christopher D Gregory; Jean-Michel Sallenave; A John Simpson
Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment.
The American journal of pathology 2009;174(4):1338-46.
2009: Thomas Vargues; Gareth J Morrison; Emily S Seo; David J Clarke; Helen L Fielder; Julien Bennani; Uday Pathania; Fiona Kilanowski; Julia R Dorin; John R W Govan; C Logan Mackay; Dusan Uhrín; Dominic J Campopiano
Efficient production of human beta-defensin 2 (HBD2) in Escherichia coli.
Protein and peptide letters 2009;16(6):668-76.
2008: S Josefin Bartholdson; Alan Brown; Ben R Mewburn; David J Clarke; Stephen C Fry; Dominic J Campopiano; John R W Govan
Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complex.
Microbiology (Reading, England) 2008;154(Pt 8):2513-21.
2008: Anthony De Soyza; alba silipo; Rosa Lanzetta; John R W Govan; Antonio Molinaro
Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides.
Innate immunity 2008;14(3):127-44.
2008: Karen Taylor; David J Clarke; Bryan McCullough; Wutharath Chin; Emily Seo; De Yang; Joost Oppenheim; Dusan Uhrin; John R W Govan; Dominic J Campopiano; Derek MacMillan; Perdita E Barran; Julia R Dorin
Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta-defensin 3.
The Journal of biological chemistry 2008;283(11):6631-9.
2007: Dervla T Kenna; Catherine J Doherty; Juliet Foweraker; Lisa Macaskill; Victoria A Barcus; John R W Govan
Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.
Microbiology (Reading, England) 2007;153(Pt 6):1852-9.
2007: Alan Brown; John R W Govan
Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples.
Journal of clinical microbiology 2007;45(6):1920-6.
2007: Karen Taylor; Bryan McCullough; David J Clarke; Ross J Langley; Tali Pechenick; Adrian Hill; Dominic J Campopiano; Perdita E Barran; Julia R Dorin; John R W Govan
Covalent dimer species of beta-defensin Defr1 display potent antimicrobial activity against multidrug-resistant bacterial pathogens.
Antimicrobial agents and chemotherapy 2007;51(5):1719-24.
2007: Ximena P Ortega; Silvia T Cardona; Alan Brown; Slade Loutet; Ronald S Flannagan; Dominic J Campopiano; John R W Govan; Miguel A Valvano
A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability.
Journal of bacteriology 2007;189(9):3639-44.
2007: John R W Govan; Alan Brown; Andrew M Jones
Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
Future microbiology 2007;2(2):153-64.
2006: John R W Govan
Multidrug-resistant pulmonary infection in cystic fibrosis--what does 'resistant' mean?
Journal of medical microbiology 2006;55(Pt 12):1615-7.
2006: P M Farrell; John R W Govan
Pseudomonas serology: confusion, controversy, and challenges.
Thorax 2006;61(8):645-7.
2006: Elke Vanlaere; Faiza Hansraj; Peter Vandamme; John R W Govan
Growth in Stewart's medium is a simple, rapid and inexpensive screening tool for the identification of Burkholderia cepacia complex.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2006;5(2):137-9.
2006: Dervla T Kenna; Hasan Yesilkaya; Ken J Forbes; Victoria A Barcus; Peter Vandamme; John R W Govan
Distribution and genomic location of active insertion sequences in the Burkholderia cepacia complex.
Journal of medical microbiology 2006;55(Pt 1):1-10.
2005: Silvia Campana; Giovanni Taccetti; Novella Ravenni; F Favari; Lisa Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; giovanna stassi; M Trancassini; D Tovagliari; A Lavitola; Catherine J Doherty; T Coenye; John R W Govan; P Vandamme
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.
Journal of clinical microbiology 2005;43(10):5136-42.
2005: Elke Vanlaere; Tom Coenye; Emly Samyn; Caroline Van den Plas; John R W Govan; Frans De Baets; Kris De Boeck; Christiane Knoop; Peter Vandamme
A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria.
FEMS microbiology letters 2005;249(2):303-7.
2005: Ross J Langley; Dervla T Kenna; Josefin Bartholdson; Dominic J Campopiano; John R W Govan
Temperate bacteriophages DK4 and BcepMu from Burkholderia cenocepacia J2315 are identical.
FEMS immunology and medical microbiology 2005;45(2):349-50.
2005: Deborah A Lewis; Andrew Jones; Julian Parkhill; David P Speert; John R W Govan; John J LiPuma; Stephen Lory; A Kevin Webb; Eshwar Mahenthiralingam
Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain.
American journal of respiratory cell and molecular biology 2005;33(1):56-64.
2005: Jonathan W McMichael; AI Maxwell; K Hayashi; K Taylor; William A H Wallace; John R W Govan; Julia R Dorin; Jean-Michel Sallenave
Antimicrobial activity of murine lung cells against Staphylococcus aureus is increased in vitro and in vivo after elafin gene transfer.
Infection and immunity 2005;73(6):3609-17.
2005: Andrew M Jones; Mary E Dodd; John R W Govan; Catherine J Doherty; Catherine M Smith; Barbara J Isalska; A Kevin Webb
Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
American journal of respiratory and critical care medicine 2005;171(3):257-60.
2004: Dominic J Campopiano; David J Clarke; Nick C Polfer; Perdita E Barran; Ross J Langley; John R W Govan; Alison Maxwell; Julia R Dorin
Structure-activity relationships in defensin dimers: a novel link between beta-defensin tertiary structure and antimicrobial activity.
The Journal of biological chemistry 2004;279(47):48671-9.
2004: Andrew M Jones; Mary E Dodd; John R W Govan; Victoria A Barcus; Catherine J Doherty; J Morris; A Kevin Webb
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
Thorax 2004;59(11):948-51.
2004: Kris De Boeck; Anne Malfroot; Lutgardis Van Schil; Patrick LEBECQUE; Christiane Knoop; John R W Govan; C Doherty; S Laevens; Peter Vandamme
Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2004;23(6):851-6.
2004: Anthony De Soyza; K Morris; Andrew McDowell; C Doherty; Linda Archer; J Perry; John R W Govan; Paul A Corris; Kate Gould
Prevalence and clonality of Burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation.
Thorax 2004;59(6):526-8.
2004: Frank Peter Edenborough; H R Stone; S J Kelly; PM Zadik; Catherine J Doherty; John R W Govan
Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2004;3(1):37-44.
2004: Donald J Davidson; Sheila Webb; Peter Teague; John R W Govan; Julia R Dorin
Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load.
Pathobiology : journal of immunopathology, molecular and cellular biology 2004;71(3):152-8.
2003: John R W Govan
The Burkholderia cepacia complex and cytokine induction: an inflammatory tale.
Pediatric research 2003;54(3):294-6.
2003: M Magalhães; C Doherty; John R W Govan; Peter Vandamme
Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients.
The Journal of hospital infection 2003;54(2):120-3.
2003: Tom Coenye; Peter Vandamme; John J LiPuma; John R W Govan; Eshwar Mahenthiralingam
Updated version of the Burkholderia cepacia complex experimental strain panel.
Journal of clinical microbiology 2003;41(6):2797-8.
2003: Andrew M Jones; John R W Govan; Catherine J Doherty; Mary E Dodd; Barbara J Isalska; TN Stanbridge; A Kevin Webb
Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak.
Thorax 2003;58(6):525-7.
2003: Ross Langley; Dervla T Kenna; Peter Vandamme; Rebecca Ure; John R W Govan
Lysogeny and bacteriophage host range within the Burkholderia cepacia complex.
Journal of medical microbiology 2003;52(Pt 6):483-90.
2003: Dervla T Kenna; Victoria A Barcus; Ross J Langley; Peter Vandamme; John R W Govan
Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex.
FEMS immunology and medical microbiology 2003;35(2):87-92.
2003: Peter Vandamme; Barry Holmes; Tom Coenye; Johan Goris; Eshwar Mahenthiralingam; John J LiPuma; John R W Govan
Burkholderia cenocepacia sp. nov.--a new twist to an old story.
Research in microbiology 2003;154(2):91-6.
2002: John R W Govan
Insights into cystic fibrosis microbiology from the European tobramycin trial in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2002;1(Suppl 2):203-8.
2002: Andrew M Jones; Mary E Dodd; Catherine J Doherty; John R W Govan; A Kevin Webb
Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.
Thorax 2002;57(11):924-5.
2002: M E Hodson; C G Gallagher; John R W Govan
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2002;20(3):658-64.
2002: Sazini Nzula; Peter Vandamme; John R W Govan
Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex.
The Journal of antimicrobial chemotherapy 2002;50(2):265-9.
2002: John R W Govan
TOBI: reducing the impact of pseudomonal infection.
Hospital medicine (London, England : 1998) 2002;63(7):421-5.
2002: Peter Vandamme; Deborah Henry; Tom Coenye; Sazini Nzula; Marc Vancanneyt; John J LiPuma; David P Speert; John R W Govan; Eshwar Mahenthiralingam
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools.
FEMS immunology and medical microbiology 2002;33(2):143-9.
2002: Andrew M Jones; A Kevin Webb; John R W Govan; C Anthony Hart; Martin J Walshaw
Pseudomonas aeruginosa cross-infection in cystic fibrosis.
Lancet 2002;359(9305):527-8.
2001: A M Jones; John R W Govan; Catherine J Doherty; Mary E Dodd; Barbara J Isalska; TN Stanbridge; A K Webb
Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.
Lancet 2001;358(9281):557-8.
2001: A John Simpson; William A H Wallace; ME Marsden; John R W Govan; David J Porteous; Christopher Haslett; Jean-Michel Sallenave
Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(3):1778-86.
2001: Tom Coenye; S Laevens; Anne Willems; M Ohlén; W Hannant; John R W Govan; Monique Gillis; Enevold Falsen; Peter Vandamme
Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples.
International journal of systematic and evolutionary microbiology 2001;51(Pt 3):1099-107.
2001: Eduardo Berriatua; I Ziluaga; C Miguel-Virto; P Uribarren; Ramón A Juste; S Laevens; Peter Vandamme; John R W Govan
Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection.
Journal of clinical microbiology 2001;39(3):990-4.
2000: Sazini Nzula; Peter Vandamme; John R W Govan
Sensitivity of the Burkholderia cepacia complex and Pseudomonas aeruginosa to transducing bacteriophages.
FEMS immunology and medical microbiology 2000;28(4):307-12.
2000: Tom Coenye; Enevold Falsen; Bart Hoste; M Ohlén; Johan Goris; John R W Govan; Monique Gillis; Peter Vandamme
Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov.
International journal of systematic and evolutionary microbiology 2000;50 Pt 2():887-99.
2000: John R W Govan
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.
Journal of the Royal Society of Medicine 2000;93 Suppl 38():40-5.
2000: Michael Hutchison; E C Bonell; Ian R Poxton; John R W Govan
Endotoxic activity of lipopolysaccharides isolated from emergent potential cystic fibrosis pathogens.
FEMS immunology and medical microbiology 2000;27(1):73-7.
1999: Sylvia H Duncan; Catherine J Doherty; John R W Govan; S Neogrady; Peter Galfi; Colin S Stewart
Characteristics of sheep-rumen isolates of Pseudomonas aeruginosa inhibitory to the growth of Escherichia coli O157.
FEMS microbiology letters 1999;180(2):305-10.
1999: Michael Hutchison; John R W Govan
Pathogenicity of microbes associated with cystic fibrosis.
Microbes and infection / Institut Pasteur 1999;1(12):1005-14.
1999: Tom Coenye; Leo M Schouls; John R W Govan; Karel Kersters; Peter Vandamme
Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting.
International journal of systematic bacteriology 1999;49 Pt 4():1657-66.
1999: E Evans; Ian R Poxton; John R W Govan
Lipopolysaccharide chemotypes of Burkholderia cepacia.
Journal of medical microbiology 1999;48(9):825-32.
1999: A John Simpson; AI Maxwell; John R W Govan; Christopher Haslett; Jean-Michel Sallenave
Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens.
FEBS letters 1999;452(3):309-13.
1999: Tom Coenye; Enevold Falsen; Marc Vancanneyt; Bart Hoste; John R W Govan; Karel Kersters; Peter Vandamme
Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov.
International journal of systematic bacteriology 1999;49 Pt 2():405-13.
1999: Tom Coenye; B Holmes; Karel Kersters; John R W Govan; Peter Vandamme
Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al. 1995 and Burkholderia vandii Urakami et al. 1994 are junior synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al. 1994, respectively.
International journal of systematic bacteriology 1999;49 Pt 1():37-42.
1998: John R W Govan; Peter Vandamme
Agricultural and medical microbiology: a time for bridging gaps.
Microbiology (Reading, England) 1998;144 ( Pt 9)():2373-5.
1998: Gillian M Morrison; Donald J Davidson; Fiona M Kilanowski; Diana Borthwick; K Crook; AI Maxwell; John R W Govan; Julia R Dorin
Mouse beta defensin-1 is a functional homolog of human beta defensin-1.
Mammalian genome : official journal of the International Mammalian Genome Society 1998;9(6):453-7.
1998: Michael Hutchison; Ian R Poxton; John R W Govan
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes.
Infection and immunity 1998;66(5):2033-9.
1997: Peter Vandamme; B Holmes; Marc Vancanneyt; Tom Coenye; Bart Hoste; Renata Coopman; Hilde Revets; S Lauwers; Monique Gillis; Karel Kersters; John R W Govan
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
International journal of systematic bacteriology 1997;47(4):1188-200.
1997: J E Hughes; J Stewart; G Robin Barclay; John R W Govan
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.
Infection and immunity 1997;65(10):4281-7.
1996: John R W Govan; J E Hughes; Peter Vandamme
Burkholderia cepacia: medical, taxonomic and ecological issues.
Journal of medical microbiology 1996;45(6):395-407.
1996: K Cheng; Rosalind Smyth; John R W Govan; C Doherty; Craig Winstanley; N Denning; D P Heaf; H K F Van Saene; C Anthony Hart
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Lancet 1996;348(9028):639-42.
1996: John R W Govan; V Deretic
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.
Microbiological reviews 1996;60(3):539-74.
1996: P J Tatnell; N J Russell; John R W Govan; P Gacesa
Colonisation of cystic fibrosis patients by non-mucoid Pseudomonas aeruginosa--characterisation of the alginate from mucoid variants.
Biochemical Society transactions 1996;24(3):406S.
1996: P J Tatnell; N J Russell; John R W Govan; P Gacesa
Characterisation of alginates from mucoid strains of Pseudomonas aeruginosa.
Biochemical Society transactions 1996;24(3):404S.
1995: I N Simpson; R Hunter; John R W Govan
Are all carbapenems created equal?
The Journal of antimicrobial chemotherapy 1995;35(5):707-8.
1995: D Shaw; Ian R Poxton; John R W Govan
Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide.
FEMS immunology and medical microbiology 1995;11(2):99-106.
1995: Donald J Davidson; Julia R Dorin; Gerry McLachlan; V Ranaldi; D Lamb; C Doherty; John R W Govan; David J Porteous
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens.
Nature genetics 1995;9(4):351-7.
1995: S L Butler; C J Doherty; J E Hughes; J W Nelson; John R W Govan
Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?
Journal of clinical microbiology 1995;33(4):1001-4.
1994: I N Simpson; J Finlay; D J Winstanley; N Dewhurst; J W Nelson; S L Butler; John R W Govan
Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
The Journal of antimicrobial chemotherapy 1994;34(3):353-61.
1994: S L Butler; J W Nelson; Ian R Poxton; John R W Govan
Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.
FEMS immunology and medical microbiology 1994;8(4):285-92.
1994: J W Nelson; S L Butler; D Krieg; John R W Govan
Virulence factors of Burkholderia cepacia.
FEMS immunology and medical microbiology 1994;8(2):89-97.
1993: I N Simpson; R Hunter; John R W Govan; J W Nelson
Do all Pseudomonas cepacia produce carbapenemases?
The Journal of antimicrobial chemotherapy 1993;32(2):339-41.
1993: John R W Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A Kevin Webb
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.
Lancet 1993;342(8862):15-9.
1993: J W Nelson; S L Butler; P H Brown; A P Greening; John R W Govan
Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
Journal of medical microbiology 1993;39(1):39-47.
1993: C Lewin; C Doherty; John R W Govan
In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia.
Antimicrobial agents and chemotherapy 1993;37(1):123-5.
1993: John R W Govan; J W Nelson
Microbiology of cystic fibrosis lung infections: themes and issues.
Journal of the Royal Society of Medicine 1993;86 Suppl 20():11-8.
1992: John R W Govan; D W Martin; V P Deretic
Mucoid Pseudomonas aeruginosa and cystic fibrosis: the role of mutations in muc loci.
FEMS microbiology letters 1992;79(1-3):323-9.
1992: John R W Govan; J W Nelson
Microbiology of lung infection in cystic fibrosis.
British medical bulletin 1992;48(4):912-30.
1992: J W Nelson; G R Barclay; L R Micklem; Ian R Poxton; John R W Govan
Production and characterisation of mouse monoclonal antibodies reactive with the lipopolysaccharide core of Pseudomonas aeruginosa.
Journal of medical microbiology 1992;36(5):358-65.
1992: John R W Govan; Patxi Sarasola; D J Taylor; P J Tatnell; N J Russell; P Gacesa
Isolation of a mucoid alginate-producing Pseudomonas aeruginosa strain from the equine guttural pouch.
Journal of clinical microbiology 1992;30(3):595-9.
1991: J W Nelson; C J Doherty; P H Brown; A P Greening; Mary E Kaufmann; John R W Govan
Pseudomonas cepacia in inpatients with cystic fibrosis.
Lancet 1991;338(8781):1525.
1990: M W Tredgett; C Doherty; John R W Govan
Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases.
Journal of medical microbiology 1990;32(3):169-72.
1990: J W Nelson; M W Tredgett; John K Sheehan; David J Thornton; D Notman; John R W Govan
Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis.
Infection and immunity 1990;58(6):1489-95.
1989: John R W Govan
Alginate and antibiotics.
Antibiotics and chemotherapy 1989;42():88-96.
1987: J A Raeburn; John R W Govan; W M McCrae; A P Greening; P S Collier; M E Hodson; M C Goodchild
Ciprofloxacin therapy in cystic fibrosis.
The Journal of antimicrobial chemotherapy 1987;20(3):295-6.
1987: John R W Govan; C Doherty; S Glass
Rational parameters for antibiotic therapy in patients with cystic fibrosis.
Infection 1987;15(4):300-7.
1983: R T Cullen; W M McCrae; John R W Govan; J A Raeburn; T M Ingram
Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
The Journal of antimicrobial chemotherapy 1983;12 Suppl A():369-75.